Kaylee Tseng

Kaylee Tseng

Auto-generated profile, based on publicly available information

Kaylee Tseng

Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, United States

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
KWKate L White
Kate L White
JSJitin Singla
Jitin Singla
VLValentina Loconte
Valentina Loconte
JCJian-Hua Chen
Jian-Hua Chen
AEAxel Ekman
Axel Ekman
RSRaymond Charles Stevens
Raymond Charles Stevens
Subcellular maps of β cells reveal the coordinated reorganization of organelles during insulin secretion.

8 September 2023 in Advanced Functional Materials
Verified
Journal Article
Closed access
FZFatemeh Zehtabi
Fatemeh Zehtabi
AGAnkit Gangrade
Ankit Gangrade
KTKaylee Tseng
Kaylee Tseng
RHReihaneh Haghniaz
Reihaneh Haghniaz
RAReza Abbasgholizadeh
Reza Abbasgholizadeh
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

26 October 2022 in Macromolecular Bioscience
Verified
Journal Article
Closed access
FZFatemeh Zehtabi
Fatemeh Zehtabi
HMHossein Montazerian
Hossein Montazerian
RHReihaneh Haghniaz
Reihaneh Haghniaz
KTKaylee Tseng
Kaylee Tseng
NMNeda Mohaghegh
Neda Mohaghegh
Ali  KhademhosseiniAli Khademhosseini
Ali Khademhosseini

3 November 2023 in SLAS Technology
Verified
Journal Article
Open access
NHNathan Ho
Nathan Ho
KTKaitlyn Tang
Kaitlyn Tang
VNVy Ngo
Vy Ngo
ILIsabella Livits
Isabella Livits
AMAlayne Morrel
Alayne Morrel
ECEun Ji Chung
Eun Ji Chung
Cholera is a waterborne disease caused by Vibrio cholerae bacteria generally transmitted through contaminated food or water sources. Although it has been eradicated in most Western countries, cholera continues to be a highly transmitted and lethal disease in several African and Southeast Asian countries. Unfortunately, current diagnostic methods for cholera have challenges including high cost or delayed diagnoses that can lead to increased disease transmission during pandemics, while current treatments such as therapeutic drugs and vaccines have limited efficacy against drug-resistant serogroups of Vibrio cholerae. As such, new solutions that can treat cholera in an efficient manner that avoids Vibrio cholerae's adaptive immunity are needed. Nanoparticles (NPs) are a suitable platform for enhancing current theranostic tools because of their biocompatibility and ability to improve drug circulation and targeting. Nanoparticle surfaces can also be modified with various protein receptors targeting cholera toxins produced by Vibrio cholerae. This review will address recent developments in diagnostics, therapeutics, and prevention against cholera particularly focusing on the use of metal-based nanoparticles and organic nanoparticles. We will then discuss future directions regarding nanoparticle research for cholera.